# Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

> **NCT07261891** · NA · RECRUITING · sponsor: **prof. dr. Rik Schrijvers** · enrollment: 20 (estimated)

## Conditions studied

- Primary Immunodeficiency Diseases (PID)

## Interventions

- **DIAGNOSTIC_TEST:** blood sampling

## Key facts

- **NCT ID:** NCT07261891
- **Lead sponsor:** prof. dr. Rik Schrijvers
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-21
- **Primary completion:** 2028-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07261891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07261891, "Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07261891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*